Skip to main content
Log in

Steroid-sparing effect of tacrolimus in a patient with juvenile dermatomyositis presenting poor bioavailability of cyclosporine A

  • Short Report
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Cassidy JT, Petty RE (2001) Juvenile dermatomyositis. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology, 4th edn. Saunders, Philadelphia, pp 465–504

  2. Cooney FG, Habucky K, Hoppu K (1997) Cyclosporin pharmacokinetics in pediatric transplant recipients. Clin Pharmacokinet 32: 481–495

    CAS  PubMed  Google Scholar 

  3. Thomson AW, Carroll PB, McCauley J (1993) FK506: A novel immunosuppressant for treatment of autoimmune disease. Springer Semin Immunopathol 14: 323–344

    CAS  PubMed  Google Scholar 

  4. Zeller V, Cohen P, Prieur AM, Guillevin L (1996) Cyclosporin A therapy in refractory juvenile dermatomyositis. Experience and long-term follow-up of six cases. J Rheumatol 23: 1424–1427

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yusei Ohshima.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamada, A., Ohshima, Y., Omata, N. et al. Steroid-sparing effect of tacrolimus in a patient with juvenile dermatomyositis presenting poor bioavailability of cyclosporine A. Eur J Pediatr 163, 561–562 (2004). https://doi.org/10.1007/s00431-004-1497-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-004-1497-7

Keywords

Navigation